Roumell Asset Management, LLC - TRANSCEPT PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Roumell Asset Management, LLC ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$4,555,000
+17.9%
2,249,314
+15.8%
5.11%
+12.8%
Q2 2014$3,865,000
-38.2%
1,942,184
-4.4%
4.53%
-28.0%
Q1 2014$6,258,000
-14.1%
2,031,874
-6.3%
6.29%
-18.6%
Q4 2013$7,282,000
+1.5%
2,167,361
-3.9%
7.73%
+32.4%
Q3 2013$7,173,000
+3.0%
2,255,691
-2.1%
5.84%
+22.3%
Q2 2013$6,962,0002,305,2514.77%
Other shareholders

There were no reported owners of TRANSCEPT PHARMACEUTICALS IN in Q4 2014.

NameSharesValueWeighting ↓
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders